Front Endocrinol (Lausanne) (2023) 14:1148954
SilveiraSQda SilvaLMde Campos Vieira AbibAde MouraDTHde MouraEGHSantosLBet al
GLP-1 induces a marked increase in plasma concentrations of interleukin 1 receptor antagonist.3 This would interfere with the damaging effect of IL-1 on the -cell, thus potentially increasing insulinogenesis and possibly prolonging -cell life
Oxidized glutathione (GSSG) levels in OA were not different than YA and were unchanged by GlyNAC or placebo
Efficacy and safety of canagliflozin as add-on therapy to a glucagon-like peptide-1 receptor agonist in Japanese patients with type 2 diabetes mellitus: a 52-week, open-label, phase IV study
Mecobalamin, a naturally occurring form of vitamin B12, was approved in Japan on September 24 under the brand name Rozebalamin to treat ALS.Vitamin B Injections prove to be helpful for newly diagnosed ALS patients The therapy, which will be manufactured and marketed by Eisai, is intended to slow functional decline in people with the disease
)
